Padsevonil-impurities | Pharmaffiliates

Padsevonil

Padsevonil (UCB 0942) is an orally administered small molecule compound, being developed by UCB Biopharma, for the treatment of drug refractory epilepsy and partial-onset seizures in patients with drug refractory epilepsy. Reference standards of Padsevonil API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Padsevonil - API Standards 
    [catalogue_number] => PA 16 2790000
    [category_ids] => ,78,75,70,76,82,
    [chemical_name] => 
    [weight] => 432.79
    [form] => C14H14ClF5N4O2S
    [cas] => 1294000-61-5
    [pslug] => 1294000-61-5-padsevonil-api-pa162790000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 2790000

Padsevonil - API Standards


  • Catalogue No.:PA 16 2790000

  • CAS :

    1294000-61-5

  • Molecular Formula : C14H14ClF5N4O2S

  • Molecular Weight : 432.79